| 纯度 | >90%SDS-PAGE. |
| 种属 | E.coli |
| 靶点 | laaA |
| Uniprot No | Q76KX0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-310aa |
| 氨基酸序列 | MEFIEKIREGYAAFGAYQTWYRVTGDLSSGRTPLVVIHGGPGCTHDYVDAFKDVAASGHAVIHYDQLGNGRSTHLPDKDPSFWTVGLFLEELNNLLDHLQISDNYAILGQSWGGMLGSEHAILQPKGLRAFIPANSPTCMRTWVSEANRLRKLLPEGVHETLLKHETAGTYQDPEYLAASRVFYDHHVCRVIPWPEEVARTFAAVDADPTVYHAMSGPTEFHVIGSLKDWKSTGRLSAINVPTLVISGRHDEATPLVVKPFLDEIADVRWALFEDSSHMPHVEERQACMGTVVKFLDEVCSAKYKVLKAS |
| 预测分子量 | 54.5 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于“laaA重组蛋白”的模拟参考文献示例(注：由于“laaA”可能为特定领域或拼写变体，以下内容为假设性文献，供参考)：
---
1. **标题**: *Optimization of laaA Recombinant Protein Expression in Escherichia coli*
**作者**: Smith J, Lee K, Zhang Y
**摘要**: 本研究通过优化启动子、诱导条件和培养基成分，成功在大肠杆菌中高效表达可溶性的laaA重组蛋白。实验表明，低温(25°C)和IPTG梯度诱导可显著提高蛋白产量，为后续功能研究奠定基础。
2. **标题**: *Structural Characterization of laaA Protein and Its Role in Bacterial Pathogenesis*
**作者**: García R, et al.
**摘要**: 通过X射线晶体学解析了laaA重组蛋白的三维结构，发现其具有独特的底物结合域。功能实验表明，laaA通过调控宿主细胞信号通路增强细菌侵染能力，为抗感染药物开发提供新靶点。
3. **标题**: *Functional Analysis of laaA Recombinant Protein in Plant Defense Responses*
**作者**: Chen L, Wang H, Tanaka M
**摘要**: 首次报道laaA重组蛋白在植物免疫中的作用。实验表明，外源表达laaA可激活茉莉酸信号通路，增强植物对真菌病原体的抗性，暗示其在农业生物技术中的潜在应用。
4. **标题**: *High-Yield Purification and Enzymatic Activity of laaA Recombinant Protein*
**作者**: Müller F, et al.
**摘要**: 开发了一种基于镍柱亲和层析的laaA重组蛋白纯化方案，纯度达95%。酶活分析显示，laaA具有ATP水解活性，其活性依赖镁离子浓度，提示其可能参与能量代谢调控。
---
**注意**：以上文献为示例性质，实际研究中请通过学术数据库(如PubMed、Web of Science)以准确关键词检索。若“laaA”为特定领域术语，建议核实拼写或补充背景信息以精准定位文献。
**Background of LaaA Recombinant Protein**
LaaA (Listeria adhesion protein A) recombinant protein is a genetically engineered molecule derived from the pathogenic bacterium *Listeria monocytogenes*. LaaA plays a critical role in the bacterium’s ability to adhere to and invade host cells, particularly intestinal epithelial cells, during infection. This protein facilitates the initial stages of listeriosis, a foodborne illness that can lead to severe outcomes in immunocompromised individuals, pregnant women, and newborns.
The recombinant form of LaaA is produced using biotechnological methods, such as cloning the *laaA* gene into expression vectors (e.g., *E. coli* or yeast systems) followed by purification. This approach allows large-scale production of the protein while eliminating the risks associated with handling the live pathogen. Researchers have focused on characterizing LaaA’s structural and functional properties to understand its role in bacterial pathogenesis. Studies reveal that LaaA interacts with host cell receptors, such as glycosylated surface molecules, to mediate bacterial attachment—a key step preceding invasion and intracellular survival.
Beyond its pathological significance, LaaA recombinant protein has become a valuable tool in vaccine development and diagnostic applications. Its immunogenic properties make it a potential candidate for subunit vaccines aimed at inducing protective immunity against *Listeria*. Additionally, LaaA-based assays are used to detect *Listeria*-specific antibodies in clinical or environmental samples. Recent advances in protein engineering have also explored modifying LaaA to enhance its stability or specificity for targeted therapeutic delivery systems.
Despite progress, challenges remain in optimizing expression yields, minimizing endotoxin contamination (in prokaryotic systems), and ensuring proper post-translational modifications. Ongoing research continues to refine production techniques and expand applications, underscoring LaaA’s dual role as a virulence factor and a biotechnological asset.
×
